TY - JOUR
T1 - Liver Disease and Treatment Needs of Asymptomatic Persons Living With Hepatitis B in Senegal
AU - Ramírez Mena, Adrià
AU - Thioubou, Mame Aissé
AU - Diallo, Kalilou
AU - Tine, Judicaël
AU - Ngom, Ndeye Fatou
AU - Fortes, Louise
AU - Ndiaye, Kiné
AU - Karasi, Jean Claude
AU - Seguin-Devaux, Carole
AU - Goedertz, Henri
AU - Diouf, Daouda
AU - Seydi, Moussa
AU - Sambou, Benjamin Amaye
AU - Arendt, Vic
AU - Wandeler, Gilles
AU - Manga, Noël Magloire
AU - for SEN-B and CARES
N1 - Financial support: This work was supported by the Swiss National Science Foundation (PZ00P3_154730); the Ministère des Affaires étrangères et européennes de Luxembourg - Direction de la coopération au développement et de l’action humanitaire; and an investigator-initiated study from Roche Diagnostics.
© The Author(s) 2022. Published by Oxford University Press on behalf of Infectious Diseases Society of America.
PY - 2022/11/1
Y1 - 2022/11/1
N2 - The prevalence of active hepatitis B among asymptomatic persons remains unclear in Africa. Of 1206 newly diagnosed persons in Senegal, 12.3% had significant fibrosis and 31.3% had hepatitis B virus (HBV) DNA levels >2000 IU/mL. Overall, 128 (12.9%) were eligible for antiviral therapy. Generalized HBV screening allowed the identification of a large population requiring HBV care.
AB - The prevalence of active hepatitis B among asymptomatic persons remains unclear in Africa. Of 1206 newly diagnosed persons in Senegal, 12.3% had significant fibrosis and 31.3% had hepatitis B virus (HBV) DNA levels >2000 IU/mL. Overall, 128 (12.9%) were eligible for antiviral therapy. Generalized HBV screening allowed the identification of a large population requiring HBV care.
KW - hepatitis B
KW - liver fibrosis
KW - Senegal
UR - http://www.scopus.com/inward/record.url?scp=85145069123&partnerID=8YFLogxK
UR - https://pubmed.ncbi.nlm.nih.gov/36381617
U2 - 10.1093/ofid/ofac558
DO - 10.1093/ofid/ofac558
M3 - Article
C2 - 36381617
SN - 2328-8957
VL - 9
JO - Open Forum Infectious Diseases
JF - Open Forum Infectious Diseases
IS - 11
M1 - ofac558
ER -